Ophthalmic Cons of Long Island — Oceanside, New York

Ophthalmic Cons of Long Island is a clinical research site located in Oceanside, New York, United States 11572.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Ophthalmic Cons of Long Island has participated in 4 clinical trials.

Therapeutic areas: Wet Macular Degeneration, Diabetic Macular Edema, Neovascular Age-related Macular Degeneration.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ophthalmic Cons of Long Island?

Ophthalmic Cons of Long Island has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ophthalmic Cons of Long Island conducted?

Ophthalmic Cons of Long Island has 4 clinical trials on record. Their work covers Wet Macular Degeneration, Diabetic Macular Edema, Neovascular Age-related Macular Degeneration.

Is Ophthalmic Cons of Long Island accredited by Crixeo Health?

Ophthalmic Cons of Long Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ophthalmic Cons of Long Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.